Significant of Adiponectin in gastropathy A case control study

Significant of Adiponectin in gastropathy A case-control study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20190820001

Enrollment

Registered

2019-08-20

Start date

2018-08-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

level of adiponectin adiponectin &#44

Interventions

None listed

Eligibility

Sex/Gender

All

Age

22 Years to 65 Years

Inclusion criteria

Inclusion criteria: patients with gastric pain

Exclusion criteria

Exclusion criteria: patients with gastric cancer

Design outcomes

Primary

Measure	Time frame
level of adiponectin in serum of patients with gastropathy one and halve hour ELISA method	—

Secondary

Measure	Time frame
adiponectin had no effect on development of gastropathy one hour ELISA	—

Countries

Iraq

Contacts

Public Contactbatool mahdi

abas_susan@yahoo.com07702553215

Outcome results